Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Point-Link Network Services Limited is the authorized national representative in Nigeria for Shijiazhuang Yiling Pharmaceutical, a prominent developer of Traditional Chinese Medicine (TCM). The company is primarily responsible for the regulatory navigation, marketing, and distribution of innovative herbal therapies, most notably Lianhua Qingke Tablets and Lianhua Qingwen Capsules. Lianhua Qingke is a NAFDAC-approved treatment specifically indicated for clearing lung heat and relieving coughs associated with acute and chronic bronchitis. Point-Link acts as a strategic bridge between Chinese pharmaceutical research and the West African healthcare market, providing medical services and sales support for evidence-based TCM products. Their operations focus on integrating herbal-based respiratory treatments into the local clinical landscape to address public health challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nigerian national representatives for TCM services and sales of Lianhua Qingke Tablets.